INVO Bioscience Inc. (INVO)
NASDAQ: INVO
· Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM
INVO Bioscience Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Product Revenue | 81.57K |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.55B | 9.07B | 1.51M | 2.65M | 1.44M | 1.86M | 1.26M | 2.04M | 2.51M | 2.84M | 2.48M | 2.44M | 2.69M | 2.43M | 2.42M | 2.05M | 2.12M | 1.75M | 1.46M | 1.25M | 1.6M | 1.04M | 891.01K | 669.15K | 527.57K | 624.58K | 299.55K | 1.88M | 230K | 267.28K | 199.69K | 198.55K | 205.1K | 276.72K | 218.75K | 1.46M | 195.61K | 235.37K | 116.86K | 113.46K | 133.26K |
| Selling, General, and Administrative Revenue Growth | -71.85% | +598952.11% | -42.79% | +83.78% | -22.38% | +47.65% | -38.46% | -18.57% | -11.78% | +14.82% | +1.30% | -9.27% | +10.71% | +0.70% | +17.93% | -3.11% | +20.65% | +19.76% | +16.84% | -21.45% | +53.24% | +16.82% | +33.15% | +26.84% | -15.53% | +108.51% | -84.10% | +719.11% | -13.95% | +33.84% | +0.58% | -3.19% | -25.88% | +26.50% | -84.97% | +643.92% | -16.89% | +101.40% | +3.00% | -14.86% | n/a |
| Research and Development Revenue | 265.66M | 489.66M | n/a | n/a | 4.88K | 5.91K | 2.67K | 83.85K | 73.52K | 73.83K | 175.27K | 190.76K | 104.18K | 63.76K | 55.39K | 31.02K | 66.27K | 220.93K | 112.55K | 34.89K | 30.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -45.74% | n/a | n/a | -100.00% | -17.39% | +121.40% | -96.82% | +14.05% | -0.43% | -57.87% | -8.12% | +83.11% | +63.40% | +15.10% | +78.59% | -53.20% | -70.01% | +96.30% | +222.59% | +16.11% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |